| Literature DB >> 23230413 |
Abstract
STUDYEntities:
Year: 2012 PMID: 23230413 PMCID: PMC3516454 DOI: 10.1055/s-0031-1298613
Source DB: PubMed Journal: Evid Based Spine Care J ISSN: 1663-7976
Fig. 1Subject selection.
Demographic data and differences in reoperation rates between obese and non-obese subjects.
| No. of subjects | BMI > 35 (%) | Total reoperations (%) | Reoperations non-obese (BMI < 35) subjects (%) | Reoperations obese (BMI ≥ 35) subjects (%) | ||
|---|---|---|---|---|---|---|
| 3388 | 332 (9.8) | 101 (3.0) | 85 (2.8) | 16 (4.8) | ||
| Male | 1770 | 148 (8.4) | 43 (2.4) | 42 (2.6) | 1 (0.7) | |
| Female | 1620 | 184 (11.4) | 59 (3.6) | 59 (4.1) | 14 (7.6) | |
| 20–29 | 245 | 19 (7.8) | 9 (3.7) | 8 (3.5) | 1 (5.3) | |
| 30–44 | 791 | 73 (9.2) | 28 (3.5) | 25 (3.5) | 3 (4.1) | |
| 45–59 | 1036 | 120 (11.6) | 27 (2.6) | 24 (2.6) | 3 (2.5) | |
| 60–74 | 927 | 104 (11.2) | 39 (4.2) | 34 (4.1) | 5 (5) | |
| 75+ | 391 | 19 (4.9) | 13 (3.3) | 10 (2.7) | 3 (15.7) | |
| Decompression | 2095 | 166 (7.9) | 47 (2.2) | 39 (2.0) | 8 (4.8) | |
| Decompression with instrumentation or fusion | 1130 | 159 (14.1) | 41 (3.6) | 35 (3.6) | 6 (3.8) | |
| Arthroplasty | 25 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Deformity correction | 138 | 8 (5.8) | 13 (9.4) | 12 (9.2) | 1 (12.5) |
Fig. 2Unadjusted relative risk of reoperation within 3 months of elective lumbar surgery (solid lines represent 95% confidence intervals).
Adjusted point estimates (odds ratios) for early reoperation.
| Variable | Odds ratio | 95% Confidence interval |
|---|---|---|
| Obesity | 1.57 | (0.89–2.77) |
| Age | 0.99 | (0.98–1.01) |
| Gender: female | 1.39 | (0.92–2.09) |
| Procedure: instrumented fusion | 1.64 | (1.05–2.56) |
| Procedure: deformity correction | 4.46 | (2.34–8.53) |
Explanation for reoperation stratified by obesity status.
| Infection (%) | Repeated nerve compression (%) | Deformity (%) | Mechanical failure (%) | Mean No. of days to reoperation from index procedure | |
|---|---|---|---|---|---|
| Obese | 8 (2.4) | 7 (2.1) | 0 (0) | 0 (0) | 12.5 |
| Non-obese | 26 (0.9) | 57 (1.9) | 1 (0.03) | 1 (0.03) | 16.8 |
| Final class of evidence-prognosis | |
|---|---|
| Study design | |
| Prospective Cohort | |
| Retrospective Cohort | • |
| Case control | |
| Case series | |
| Methods | |
| Patients at similar point in course of treatment | • |
| F/U ≥ 85% | • |
| Similarity of treatment protocols for patient groups | • |
| Patients followed up long enough for outcomes to occur | • |
| Control for extraneous risk factors | |
| Overall class of evidence | III |
| The definiton of the different classes of evidence is available on page 55. | |